# Anacalypsis Therapeutics

> Greek drug-discovery biotech that raised a €300,000 pre-seed round led by Metavallon VC to advance a Parkinson's disease program.

## Why it is interesting

A first-of-its-kind local drug-discovery investment in Greece with primary investor disclosure.

## Profile

- **Latest funding:** Pre-seed — €300K (September 21, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** pre-seed
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-09-30
- **Latest funding investors:** Metavallon VC

## Key facts

- Sep 21, 2026: €300K pre-seed led by Metavallon VC

## Funding history

- Pre-seed · €300K · September 21, 2026
  Source: https://metavallon.vc/blog/metavallon-vc-invests-300k-euros-pre-seed-round-in-anacalypsis-therapeutics/

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** September 30, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/anacalypsis-therapeutics